VIRGAN gel opht 1.5 mg/g tb 5 g

7680677100017 CH-67710 S01AD09 11.07.2.
VIRGAN gel opht 1.5 mg/g tb 5 g
VIRGAN gel opht 1.5 mg/g tb 5 g
VIRGAN gel opht 1.5 mg/g tb 5 g
1 / 3
google

Details

Product number
6771001
CPT
-
Packaging group
5
Unit
g
Composition
ganciclovirum 7.5 mg, carbomerum 974P, sorbitolum, natrii hydroxidum ad pH, benzalkonii chloridum 0.375 mg, aqua ad iniectabile, ad gelatum pro 5 g.

Articles (1)

Virgan 1.5 mg/g, gel ophtalmique
Gel
5
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
27/08/2024
Patient information leaflet
Français
27/08/2024
Patient information leaflet
Italien
27/08/2024
Professional SmPC
Allemand
27/08/2024
Professional SmPC
Français
27/08/2024
Professional SmPC
Italien
27/08/2024

Detailed composition

Substance Quantity Type Category
(N/A)
7.5 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.375 MG Substance HBESI
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 29.70
Specialties list
Yes
Generic
No
SL addition date: 01/12/2021

Authorization holder

THEA Pharma S.A.

8200 Schaffhausen

Authorization information

Swissmedic authorization number
67710
Drug name
Virgan 1.5 mg/g, gel ophtalmique
Galenic form
AUGG
ATC Code
S01AD09
Authorization status
Z
Dispensation category
A
First authorization
04/12/2020
Authorization expiration date
31/12/9999
IT number
11.07.2.
Domain
Human medicine
Field of application
Behandlung der akuten, oberflächlichen Herpessimplex-Keratitis

Packaging details

Description (FR)
VIRGAN gel opht 1.5 mg/g tb 5 g
Description (DE)
VIRGAN Augengel 1.5 mg/g Tb 5 g
Market launch
04/12/2020
Narcotic (BTM)
No